BruceEMillerMD

PubMed

• 2 citations
  BMI- and age-related associations with mortality from COVID-19.
  T. M. Austin, B. E. Miller> ;Anaesthesia. 2021 Apr 11
• Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD.
  Bowler, R.,Allinder, M.,Jacobson, S.,Miller, A.,Miller, B.,Tal-Singer, R.,Locantore, N.> ;BMJ Open Respir Res. 2019 Apr 09
• Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patie...
  Johansson, S. L.,Wulf-Johansson, H.,Schlosser, A.,Titlestad, I. L.,Miller, B.,Tal-Singer, R.,Holmskov, U.,Vestbo, J.,Sørensen, G. L.> ;ERJ Open Res. 2019 Apr 27
• Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
  Rønnow, S. R.,Sand, JMB.,Langholm, L. L.,Manon-Jensen, T.,Karsdal, M. A.,Tal-Singer, R.,Miller, B. E.,Vestbo, J.,Leeming, D. J.> ;Respir. Res.. 2019 Apr 03
• Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort.
  Rønnow, S. R.,Langholm, L. L.,Sand, JMB.,Thorlacius-Ussing, J.,Leeming, D. J.,Manon-Jensen, T.,Tal-Singer, R.,Miller, B. E.,Karsdal, M. A.,Vestbo, J.> ;Sci Rep. 2019 Mar 13
• Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.
  Faner, R.,Morrow, J. D.,Casas-Recasens, S.,Cloonan, S. M.,Noell, G.,López-Giraldo, A.,Tal-Singer, R.,Miller, B. E.,Silverman, E. K.,Agustí, A.,Hersh, C. P.> ;Respir. Res.. 2019 Jan 10
• Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.
  Mohan, D.,Forman, J. R.,Allinder, M.,McEniery, C. M.,Bolton, C. E.,Cockcroft, J. R.,MacNee, W.,Fuld, J.,Marchong, M.,Gale, N. S.,Fisk, M.,Nagarajan, S.,Cheriyan, J.,Lo...> ;Thorax. 2018 Apr 06
• Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD.
  Lazaar, A. L.,Miller, B. E.,Tabberer, M.,Yonchuk, J.,Leidy, N.,Ambery, C.,Bloomer, J.,Watz, H.,Tal-Singer, R.> ;Eur. Respir. J.. 2018 Aug 25
• Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
  Mayhew, D.,Devos, N.,Lambert, C.,Brown, J. R.,Clarke, S. C.,Kim, V. L.,Magid-Slav, M.,Miller, B. E.,Ostridge, K. K.,Patel, R.,Sathe, G.,Simola, D. F.,Staples, K. J.,Su...> ;Thorax. 2018 Feb 02
• Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
  Wang, Z.,Singh, R.,Miller, B. E.,Tal-Singer, R.,Van Horn, S.,Tomsho, L.,Mackay, A.,Allinson, J. P.,Webb, A. J.,Brookes, A. J.,George, L. M.,Barker, B.,Kolsum, U.,Donne...> ;Thorax. 2017 Dec 23
• Emphysema and Extrapulmonary Tissue Loss in COPD: A Multi-Organ Loss of Tissue Phenotype
  Bruce Miller, Miguel Divo, Edwin K Silverman> ;The European Respiratory Journal. 2018 Feb 14
• Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease.
  Huang JTJ, Bolton CE, Miller BE, Tal-Singer R, Rabinovich RA, Palmer CNA, Thomson NC, MacNee W> ;Eur. Respir. J.. 2016-10-01
• Clinical and prognostic heterogeneity of C and D GOLD groups.
  Agustí A, Rennard S, Edwards LD, MacNee W, Wouters E, Miller B, Tal-Singer R, Mullerova H, Celli B> ;Eur. Respir. J.. 2015-07-01
• 10 citations
  Cardiac catheterization in the early post-operative period after congenital cardiac surgery.
  George T. Nicholson, Dennis W. Kim, Robert N. Vincent, Brian Kogon, Bruce E. Miller, Christopher J. Petit> ;JACC. Cardiovascular Interventions. 2014 Dec 1
• Microfibrillar-associated protein 4: a potential biomarker of chronic obstructive pulmonary disease.
  Johansson SL, Roberts NB, Schlosser A, Andersen CB, Carlsen J, Wulf-Johansson H, Sækmose SG, Titlestad IL, Tornoe I, Miller B, Tal-Singer R, Holmskov U, Vestbo J, Sore...> ;Respir Med. 2014-09-01
• Lessons from ECLIPSE: a review of COPD biomarkers.
  Faner R, Tal-Singer R, Riley JH, Celli B, Vestbo J, MacNee W, Bakke P, Calverley PMA, Coxson H, Crim C, Edwards LD, Locantore N, Lomas DA, Miller BE, Rennard SI, Woute...> ;Thorax. 2014-07-01
• 110 citations
  Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.
  Jørgen Vestbo, Alvar Agusti, Emiel F.M. Wouters, Per Bakke, Peter M.A. Calverley, Bartolome R. Celli, Harvey O. Coxson, Courtney Crim, Lisa D. Edwards, Nicholas Locant...> ;American Journal of Respiratory and Critical Care Medicine. 2014 May 1
• Vitamin D, vitamin D binding protein, lung function and structure in COPD.
  Berg I, Hanson C, Sayles H, Romberger D, Nelson A, Meza J, Miller B, Wouters EFM, Macnee W, Rutten EPA, Romme EAPM, Vestbo J, Edwards L, Rennard S> ;Respir Med. 2013-10-01
• Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.
  Miller J, Edwards LD, Agustí A, Bakke P, Calverley PMA, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Ya...> ;Respir Med. 2013-09-01
• In-Hospital Shunt Occlusion in Infants Undergoing a Modified Blalock-Taussig Shunt
  Nina A Guzzetta, Bruce E Miller, Kirk R Kanter> ;The Annals of Thoracic Surgery. 2013 Jul
• The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
  Coxson HO, Dirksen A, Edwards LD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Crim C, Duvoix A, Fauerbach PN, Lomas DA, Macnee W, Mayer RJ, Miller BE, Müller N...> ;Lancet Respir Med. 2013-04-01
• Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?
  Rutten EPA, Calverley PMA, Casaburi R, Agusti A, Bakke P, Celli B, Coxson HO, Crim C, Lomas DA, Macnee W, Miller BE, Rennard SI, Scanlon PD, Silverman EK, Tal-Singer R...> ;Ann. Nutr. Metab.. 2013-01-01
• 92 citations
  Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
  Deog Kyeom Kim, Michael H. Cho, Craig P. Hersh, David A. Lomas, Bruce E. Miller, Xiangyang Kong, Per Bakke, Amund Gulsvik, Alvar Agusti, Emiel F.M. Wouters, Bartolome ...> ;American Journal of Respiratory and Critical Care Medicine. 2012 Dec 15
• Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.
  Albert P, Agusti A, Edwards L, Tal-Singer R, Yates J, Bakke P, Celli BR, Coxson HO, Crim C, Lomas DA, Macnee W, Miller B, Rennard S, Silverman EK, Vestbo J, Wouters E,...> ;Thorax. 2012-08-01
• Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.
  Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PMA, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, ...> ;PLoS ONE. 2012-01-01
• Join now to see all